Referral Art. 31, EMEA/H/A-31/1400 regarding Hydroxyzine hydrochloride/Atarax is finished
Due to summer holiday the Icelandic Medicines Agency (IMA) will not confirm receipt of clinical trial applications from 15 June to 15 August 2015.
An electronic signature leads to more effective resolution of errands, less use of paper and postal cost.
- New Executive Director of IMA
- Information to the Marketing Authorisation Holder - Nasonex
- Information to the Marketing Authorisation Holder – Colistimethate Alvogen